Aggregated price index with volume information
Summary:
- Pharmaceuticals: Generic stocks up 0.9% on average while median return up 1.1% in a day
- Pharmaceuticals: Generic stocks down -0.0% on average while median return down -0.2% in a week
- Pharmaceuticals: Generic stocks down 6.0% on average while median return down 6.3% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $RDY 1.7%, $LFVN 1.0%, $TARO 0.8%
- 1M losers are : Losers for past month are $ZTS -7.4%, $SMTI -12.4%, $BBIO -18.2%
- 1W winners are : Winners for past week are $RDY 4.4%, $TEVA 3.7%, $TARO 0.7%
- 1W losers are : Losers for past week are $BBIO -2.5%, $SMTI -5.3%, $LFVN -6.3%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 9.2%, for the past 3 months is 4.5%
In the past month for a 5 days rolling window, the highest corrrelation is 18.8%, the lowest correlation is -9.2%, the latest correlation is 3.8%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 46.7% between BBIO and TEVA
The lowest correlation is -26.8% between SMTI and TEVA
Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis' (ZTS) higher companion animal product sales are expected to have driven revenues in the first quarter of 2024 in both the United States and International segments.
PARSIPPANY, N.J., April 25, 2024--As we celebrate World Veterinary Day, the Zoetis Foundation is proud to support veterinarians around the world today and everyday by providing grant support to initiatives promoting veterinary education, mental well-being, and livelihoods. Recognizing the invaluable role veterinarians and veterinary technicians play in advancing animal health, the Foundation is committed to helping cultivate a thriving, inclusive veterinary profession.
In this article, we discuss 14 dividend growth stocks with highest growth rates. You can skip our detailed analysis of dividend growth stocks and their overall performance, and go directly to read 5 Dividend Growth Stocks with Highest Growth Rates. According to a report by ProShares, the S&P 500 Dividend Aristocrats Index, which tracks the […]
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
By David Bautz, PhD NASDAQ:COCP READ THE FULL COCP RESEARCH REPORT Business Update Update on Influenza Program Cocrystal Pharma, Inc. (NASDAQ:COCP) is developing CC-42344, a broad spectrum inhibitor of pandemic and seasonal strains of influenza A. CC-42344 targets subunit PB2, which along with PA and PB1 forms the RNA-dependent RNA polymerase. This polymerase is essential for viral replication in
In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day.
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here. The US stock market started 2024 optimistically. In the first quarter, the fund returned 8.29% (gross) and 8.09% (net) compared to 11.41% for the Russell 1000 Growth Index and […]
SALT LAKE CITY, April 18, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2024, after the stock market closes on Thursday, May 2, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors inte